Biotech Growth | Portfolio

Geographic breakdown

Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.

Data as at : 30/06/2021

Country % of total assets
USA 67.2
China 9.3
Canada 7.7
Ireland 6.6
Switzerland 2.9
Singapore 0.9
France 0.8
UK 0.5
Netherlands 0.4

Asset breakdown

Data as at : 30/06/2021

Asset % of total assets
Stock 108.9
Other -0.4
Cash/Cash equivalents -8.5

Detailed asset breakdown

Asset % of total assets
North America - stock 82.5
Asia (excl Japan) - stock 11.5
Other - stock 7.4
Europe - Mid-cap stock 2.7
UK - Small core/growth stock 1.8
Preferred stock 1.8
Europe - Small-cap stock 1.2

Industry breakdown

Data as at : 30/06/2021

Industry % of total assets
Healthcare 104.5
Preferred 1.8
Cash Equivalents -8.5

Top holdings

Data as at : 30/04/2021

Investment % of total assets
Vertex Pharmaceuticals Inc 6.1
Neurocrine Biosciences Inc 3.8
Horizon Therapeutics PLC 3.7
Immunogen Inc 3.3
Guardant Health Inc 3.0
Alexion Pharmaceuticals Inc 3.0
Aptose Biosciences Inc 2.8
Keros Therapeutics Inc 2.8
Amgen Inc 2.6
Biogen Inc 2.6

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.